(C)
The MCO and
the single pharmacy benefit manager (SPBM) must have a utilization
management (UM) program with clearly defined structures and processes designed
to maximize the effectiveness of the care provided to the member.
The MCO and
the SPBM must ensure decisions rendered through the UM program are based
on medical necessity.
(1) The UM program must
be based on written policies and procedures that include, at a minimum:
(a) The information sources used to make
determinations of medical necessity;
(b) The criteria, based on sound clinical
evidence, to make UM decisions and the specific procedures for appropriately
applying the criteria;
(c) A
specification that written UM criteria will be made available to both
contracting and non-contracting providers; and
(d) A description of how the
MCO or
SPBM will monitor the impact of the UM program to detect and correct
potential under- and over-utilization.
(2)
The MCO and SPBM's UM
programs must also ensure and document the following:
(a) An annual review and update of the UM
program.
(b) The involvement of a
designated senior physician in the UM program.
(c) The use of appropriate qualified licensed
health professionals to assess the clinical information used to support UM
decisions.
(d) The use of
board-certified consultants to assist in making medical necessity
determinations, as necessary.
(e)
That UM decisions are consistent with clinical practice guidelines as specified
in rule 5160-26-05.1 of the
Administrative Code.
The MCO may not impose conditions around the
coverage of a medically necessary medicaid-covered service unless they are
supported by such clinical practice guidelines.
(f) The reason for each denial of a service,
based on sound clinical evidence.
(g) That compensation by the
MCO or
SPBM to individuals or entities that conduct UM activities does not offer
incentives to deny, limit, or discontinue medically necessary services to any
member.
(h)
Compliance with the Mental Health Parity and Addiction
Equity Act (MHPAEA) requirements outlined in 42 CFR Part 438 Subpart K (October
1, 2021).
(3)
The MCO and
the SPBM must process requests for initial and continuing authorizations
of services from their providers and members.
The MCO and the SPBM must have
written policies and procedures to process initial requests and continuing authorizations.
Upon request, the
MCO and
SPBM's policies and procedures for initial and
continuing authorizations must be made available for review by the Ohio
department of medicaid (ODM). The
MCO and SPBM's written policies and procedures
for initial and continuing authorizations of services must also be made
available to contracting and non-contracting providers upon request. The
MCO and
SPBM must ensure and document the following occurs when processing
requests for initial and continuing authorizations of services:
(a) Consistent application of review criteria
for authorization decisions.
(b)
Consultation with the requesting provider, when necessary.
(c) Any decision to deny a service
authorization request or to authorize a service in an amount, duration, or
scope that is less than requested, must be made by a health care professional
who has appropriate clinical expertise in treating the member's condition or
disease.
(d) That a written notice
will be sent to the member and the requesting provider of any decision to
reduce, suspend, terminate, or deny a service authorization request, or to
authorize a service in an amount, duration, or scope that is less than
requested. The notice to the member must meet the requirements of division
5101:6 and rule
5160-26-08.4 of the
Administrative Code.
(e) For
standard authorization decisions, the
MCO must provide notice to the provider and
member as expeditiously as the member's health condition requires but no later
than ten calendar days following receipt of the request for service. If requested by the member,
provider, or MCO, standard authorization decisions may be extended
up to fourteen additional calendar days. If requested by the
MCO, the
MCO must
submit to ODM for prior-approval, documentation as to how the extension is in
the member's interest. If ODM approves the MCO's extension request, the
MCO must
give the member written notice of the reason for the decision to extend the
time frame and inform the member of the right to file a grievance if he or she
disagrees with that decision. The
MCO must carry out its determination as
expeditiously as the member's health condition requires and no later than the
date the extension expires.
(f) If
a provider indicates or the
MCO determines that following the standard
authorization timeframe could seriously jeopardize the member's life or health
or ability to attain, maintain, or regain maximum function, the
MCO must
make an expedited authorization decision and provide notice of the
authorization decision as expeditiously as the member's health condition
requires but no later than forty-eight hours after receipt of the request for
service. If requested by the member or MCO, expedited
authorization decisions may be extended up to fourteen additional calendar
days. If requested by the MCO, the
MCO must submit to ODM for prior-approval,
documentation as to how the extension is in the member's interest. If ODM
approves the
MCO's extension request, the
MCO must
give the member written notice of the reason for the decision to extend the
timeframe and inform the member of the right to file a grievance if he or she
disagrees with that decision. The
MCO must carry out its determination as
expeditiously as the member's health condition requires and no later than the
date the extension expires.
(g)
Upon implementation of the SPBM, for
prior
authorization
of covered outpatient drugs as defined in
42 U.S.C.
1396r-8(k)(2) (as in effect
January 1, 2022), the SPBM will
provide a response to the provider by telephone or
other telecommunication device within twenty-four hours of the initial request.
Until implementation of the SPBM, all provisions
outlined in this paragraph are applicable to the MCO.
(i)
If the prior
authorization request contains sufficient information to render a final
decision, the SPBM must provide notice to the provider of the decision within
twenty-four hours of receipt of the initial request.
(ii)
If the prior
authorization request contains insufficient information to render a final
decision, the SPBM must notify the provider of the need for additional
information within twenty-four hours of the initial request.
(iii)
If the prior
authorization request is for an emergency situation, a seventy-two hour supply
of the covered outpatient drug that was prescribed must be authorized while the
SPBM reviews the prior authorization request.
(h)
The MCO and
the SPBM must maintain and submit as directed by ODM, a record of all
authorization requests, including standard and expedited authorization requests
and any extensions granted.
MCO and SPBM records must include member
identifying information, service requested, date initial request received, any
extension requests, decision made, date of decision, date of member notice, and
basis for denial, if applicable.
(4)
Upon implementation of the SPBM, the
SPBM may, subject to ODM prior approval, implement strategies for the
management of drug utilization, and the MCO may,
subject to ODM approval, develop other UM programs.
(5)
At a minimum, the MCO has to implement a coordinated
services program (CSP) as described in rule
5160-20-01 of the Administrative
Code. The MCO has to offer care management services to any member enrolled in
CSP